• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

enVVeno Medical Corporation - Common Stock (NQ:NVNO)

11.11 +0.28 (+2.59%)
Streaming Delayed Price Updated: 1:08 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about enVVeno Medical Corporation - Common Stock

< Previous 1 2 3 Next >
News headline image
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
June 22, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
June 02, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
May 12, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
May 07, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
April 29, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
March 27, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
February 19, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 04, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Announces Reverse Stock Split
January 15, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment
November 26, 2025
Via ACCESS Newswire
News headline image
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve
November 13, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update
October 31, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
September 26, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical Updates Regulatory Status of VenoValve(R)
September 15, 2025
Via ACCESS Newswire
News headline image
enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R)
August 20, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
August 15, 2025
Via ACCESS Newswire
News headline image
Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency
August 06, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company
August 04, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 01, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
July 22, 2025
Via ACCESS Newswire
News headline image
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
July 22, 2025
Via ACCESS Newswire
News headline image
Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting
June 06, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer
May 19, 2025
Via ACCESS Newswire
News headline image
Three-Year VenoValve(R) First-in-Human Trial Data Published in the Annals of Vascular Surgery
May 13, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24
May 01, 2025
Via ACCESS Newswire
News headline image
VenoValve to be Featured During Presentation at the 47th Annual Charing Cross Symposium
April 23, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment
April 16, 2025
Via ACCESS Newswire
News headline image
The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium
March 31, 2025
Via ACCESS Newswire
News headline image
enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25
February 28, 2025
Via ACCESS Newswire
News headline image
One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum
February 19, 2025
Via ACCESS Newswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap